Contribute Try STAT+ Today

In middle school, Seth Herzon wanted to be a paleontologist, but his favorite class was shop. Even at home, that’s what he did for fun: He and his brother would go to their basement workshop, littered with tools and splintery bits of wood, and try to build things. “Oftentimes, we’d be a little too ambitious, we’d try to make things and we’d realize halfway through how hard it was: very large shelves, beds, tables. We went through a desk phase, trying to make fancy desks, which turned out to be quite hard,” he said. “What you really want is a nice cubby behind it, and the cubby is quite tricky.”

His latest construction project was even trickier, it turns out. He’d already spent two years trying to build it, from 2008 to 2010, when he first became a professor at Yale, but it was too hard, so he put it aside, the way he might a half-finished bedframe. Now, seven years later, he’s succeeded — and the result could be a promising tool with which to fight antibiotic resistance.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.